HOME >> BIOLOGY >> NEWS
Ronald Cape to receive 2007 Biotechnology Heritage Award

PHILADELPHIA and WASHINGTON, D.C.8 May 2007Chemical Heritage Foundation (CHF) and the Biotechnology Industry Organization (BIO) will present the ninth annual Biotechnology Heritage Award to Ronald Cape, cofounder of Cetus Corporation. Cape is a true visionary, a pioneer, and an entrepreneur gifted with considerable research and business skills. The award, sponsored by Invitrogen Corporation, will be presented at the 2007 BIO International Convention in Boston.

"Cetus Corporation is widely recognized as the first biotechnology company," said James C. Greenwood, president of BIO. "Ron Cape saw the potential of biotechnology even before recombinant DNA. He helped to create a new kind of company and with it launched the creation of a whole new industry."

About Ronald E. Cape

Cape, a partner at PureTech Ventures in Boston , cofounded Cetus in 1971 and served as its chairman for 20 years and CEO for 13 years, until Cetus merged with Chiron Corporation in 1991. Cetus was a pioneer in genetic engineering, developing a technology that was ultimately awarded a Nobel Prize. Cape was the founding chairman of Darwin Molecular Corporation, which was later sold to Chiroscience plc. He serves on the board of EntreMed, Inc. and Neurobiological Technologies, Inc. He also serves as a director for several privately held companies. Cape was a founding member of the Industrial Biotechnology Association (now BIO), where he served as president from 1983 to 1985. He is a fellow of the American Academy of Arts and Sciences, the American Academy of Microbiology, and the American Association for the Advancement of Science.

About the Biotechnology Heritage Award

The Biotechnology Heritage Award is presented yearly at a special ceremony during the BIO Annual International Convention to honor individuals who have contributed significantly to the growth of biotechnology through discovery, innovation, commercialization, and/or public und
'"/>

Contact: Neil Gussman
neilg@chemheritage.org
215-873-8262
Chemical Heritage Foundation
8-May-2007


Page: 1 2

Related biology news :

1. Joslins C. Ronald Kahn, MD, to discuss genetics of obesity at AACE meeting
2. Frances highest scientific honor awarded this year to Salk Institute scientist Ronald M. Evans
3. Carnegie Mellons Peter Adams receives EPA research grant
4. 2007 EURYI: 20 young researchers to receive Nobel Prize-sized awards for breakthrough ideas
5. Fedoroff, of Penn State, to receive National Medal of Science
6. Philadelphia ecologist receives top Mongolia honor
7. Nearly 90 percent of babies receive recommended newborn screening tests
8. VIB scientist receives major research grant
9. Maynard Olson receives $500,000 Gruber Genetics Prize
10. University of Cincinnati receives $1.7M to research molecular treatment of brain injury
11. UGA scientists receive $20M in federal bioenergy initiative

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Ronald Cape receive Biotechnology Heritage Award

(Date:4/17/2014)... ALBUQUERQUE, N.M. A credit-card-sized anthrax detection cartridge developed ... small business makes testing safer, easier, faster and cheaper. ... causes anthrax, is commonly found in soils all over ... illness in both humans and animals. The bacteria can ... to B. anthracis may occur through skin ...
(Date:4/17/2014)... bone marrow need to produce hydrogen sulfide in order ... a new study from the Center for Craniofacial Molecular ... USC. , Professor Songtao Shi, principal investigator on the ... the cells governs the flow of calcium ions. The ... results in osteogenesis, or the creation of new bone ...
(Date:4/17/2014)... and pathogens that devastate honeybees in Europe, Asia and ... do not appear to be impacting native honeybee populations ... researchers., The invasive pests include including Nosema microsporidia ... honeybees appear to be resilient to these invasive pests, ... control pests in Europe, Asia and the United States ...
Breaking Biology News(10 mins):Pocket-sized anthrax detector aids global agriculture 2Pocket-sized anthrax detector aids global agriculture 3East African honeybees are safe from invasive pests… for now 2East African honeybees are safe from invasive pests… for now 3
(Date:1/15/2014)... This webinar will focus on EMA and ... in biosimilars. , Regulatory frameworks are evolving many countries ... the complex nature of biopharmaceuticals makes the demonstration of ... challenging. Based on the specific aspects of biosimilar drug ...
(Date:1/15/2014)... Two champions of science, technology, engineering, ... an annual competition for middle and high school students ... STEM study. The competition presents students with real-world problems ... Aptitude, Mathematics, and Sciences is a program administered ...
(Date:1/15/2014)... Scottsdale, Arizona (PRWEB) January 15, 2014 ... growth for Scottsdale’s Brain State Technologies®. They saw continued ... University Medical Center who were awarded a $1 million ... papers published in “Brain and Behavior” a peer reviewed ...
(Date:1/15/2014)... Jan. 15, 2014 TaiGen Biotechnology Company, Limited ("TaiGen") ... with R-Pharm, a leading Russian pharmaceutical company, to develop ... Russian Federation , Turkey ... (CIS). Nemonoxacin is a novel antibiotic for the treatment of ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 3Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 4Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 5Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4
Cached News: